Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based ...
Poolbeg Pharma PLC 20 November 2024 Poolbeg Pharma plc - POLB 001 Patent Granted in United States Further strengthens Poolbeg's robust...
Poolbeg Pharma PLC 18 September 2024 Poolbeg Pharma plc...
Poolbeg Pharma PLC 12 August 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...
Poolbeg Pharma PLC 26 July 2024 Poolbeg Pharma plc Voluntary Delisting from OTCQB Market 26 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB:...
Poolbeg Pharma PLC 10 July 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Poolbeg Pharma PLC 02 July 2024 Poolbeg Pharma plc Change of Registered Address 2 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC 17 June 2024 Poolbeg Pharma plc Results of Annual General Meeting 13 June 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC 09 May 2024 Poolbeg Pharma plc Annual Report & AGM Notice 9 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Im ...
Poolbeg Pharma PLC 01 May 2024 Poolbeg Pharma plc Significant POLB 001 Patent Granted in United States Immunomodulator II patent grant...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관